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Lo–Ld coexistenceThe human immonodeﬁciency virus (HIV) envelope is enriched in cholesterol and sphingomyelin, two lipids
that sustain the formation of laterally segregated liquid-ordered ﬂuid domains in model systems. Several
evidences indicate that the high lipid order existing at the envelope may play a role in HIV pathogenesis. A
putative mechanism might involve the modulation of the membrane-perturbing function of the gp41
membrane-proximal external region (MPER). To test such hypothesis, we investigate here the effect of lipid
phase coexistence on the membrane-restructuring properties of NpreTM and CpreTM, two peptides based on
the amino- and carboxy-terminal MPER sequences, respectively. Fluid phase coexistence elicited the
fusogenic activity of NpreTM at high membrane doses and stimulated “graded” leakage at low doses. By
comparison, the effect on CpreTM was restricted to an enhancement of “all-or-none” leakage that was
consistent with the promotion of its surface aggregation. Confocal microscopy of single vesicles revealed the
preference of both peptides for liquid-disordered domains. Accordingly, we speculate that conﬁnement into
envelope ﬂuid nanodomains might boost the distinct capacities of HIV MPER hydrophobic modules for
inducing membrane defects during fusion.-UPV/EHU) and Departamento
aís Vasco, Aptdo. 644, 48080
360.
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Lipidomic analyses of the viral envelope reveal that HIV-1 buds
from cell membrane regions enriched in cholesterol (Chol) and
sphingomyelin (SPM) [1–5]. In natural membranes, SPM and Chol are
believed to segregate laterally with speciﬁc proteins into ordered
nanostructures termed “rafts”(see for recent reviews: [6,7]). The
preferential interaction of the rigid sterol ring with the long, saturated
hydrocarbon acyl chains of sphingolipids is postulated to trigger the
formation of these lipid/protein assemblies. The self-associative
properties and order parameters of lipid rafts are assumed to
resemble those of the liquid-ordered (Lo) phases observed to coexist
with liquid-disordered (Ld) phases in model membranes [6–9].
Envelope enrichment in raft-type lipids appears to be important for
maintaining the virion functionality [5,10]. Depletion of envelope Chol
with β-cyclodextrin has been shown to impair HIV-1 infection [11,12].
Similarly, treatment of virions with SPM-binding toxins blocks viral
infection [4], while inhibition of sphingolipid biosynthesis in host cells
results in the loss of HIV particle infectivity [3].According to the prevailing model of HIV-1 glycoprotein (Env)-
mediated fusion, the virus and cell membranes are brought to close
apposition through the formation of helical hairpins by the gp41
ectodomains [13,14]. It has been argued that the generation of elastic
stresses in the approaching lipid bilayers is further required for fusion
activation [15]. In the case of HIV-1, membrane remodeling at the sites
of fusion might be attained through shallow insertion of two
specialized gp41 hydrophobic domains [16,17]: the fusion peptide
(FP) inserting into the target cell membrane; and the membrane-
proximal external region (MPER), which is assumed to bury into the
external monolayer of the viral envelope.
Evidence has accumulated over the past decade supporting a role for
MPER in the membrane-restructuring processes leading to fusion-pore
opening [18,19]. MPER-based synthetic peptides have been shown to
induce fusion and permeabilization of lipid vesicles, in a Chol and SPM-
dependent fashion [20,21]. Recent mutagenesis studies support the
importance of the membrane-disrupting activity of this gp41 domain
[22]. Moreover, experimental results and modeling analyses are
consistent with the establishment of direct interactions between Chol
andMPER carboxy-terminal LWYIK sequence, whichwas identiﬁed as a
potential “cholesterol recognition/interaction amino acid consensus”
(CRAC) domain functional in fusion [23–25]. It was proposed that the
MPER-CRAC sequence might wrap and block the interfacial cholesterol
OH group through H-bond interactions, while aromatic side chains
might stack with the A ring of cholesterol [24].
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segmented into different helical domains [26,27]. We have recently
attempted to infer the functional signiﬁcance of the distinct
hydrophobicity distribution within these sequences [28]. Two
MPER-based peptides were designed with comparable solubility:
NpreTM, combining an N-terminal amphipatic-at-interface sequence
with the more hydrophobic-at-interface, aromatic-rich pre-trans-
membrane section; and CpreTM, which incorporates the N-terminal
region of the transmembrane domain (TMD) following the C-
terminus of the pre-transmembrane sequence (Fig. 1A). These
MPER modules embedded into the membrane display different
hydrophobic and hydrophilic sectors, and therefore are predicted to
inﬂuence differently the bilayer elastic properties [29–31]. Our recent
work actually provides support for the existence of two distinct lytic
mechanisms in the case of these peptides [28,32]. In particular,
NpreTM interaction induced a transient perturbation of the lipid
bilayer that resulted in partial release of the vesicle aqueous contents,
while CpreTM generated stably opened pores that allowed the
passage of solutes across vesicle membranes.
Here we analyze the differential effects of MPER hydrophobicity
distribution on membrane-restructuring of POPC:SPM:Chol lipid
bilayers that exhibit ﬂuid phase segregation. The lytic activity of the
NpreTM sequence was enhanced in comparison to ﬂuid disorderedFig. 1. (A) Schematics of gp41 ectodomain and designation of the MPER-derived NpreTM and
carboxy-terminal helical regions, respectively; MPER, membrane-proximal external region;
and numbering are derived from the prototypic HXBc2 isolate. (B) Water–membrane parti
emission spectra (excitation wavelength: 280 nm) of peptides incubated with increasing c
concentrations were: 0, 5, 10, 20, 40, 60 and 100 μM. Bottom: partitioning curves estimated
correspond to the best ﬁts of the experimental values to Eq. (1) and the calculated Kx(app)-POPC bilayers, and could be detected at peptide:lipid mole ratios (P:L)
lower than 1:1000. Vesicle fusion induced by this peptide could also
be observed, albeit at higher P:L-s (N1:100). The CpreTM lytic activity
was also enhanced with respect to pure POPC, and such phenomenon
could be ascribed to an increase in peptide surface aggregation as
inferred from amathematical pore model. However, this sequence did
not induce signiﬁcant levels of fusion under our experimental
conditions. Confocal microscopy of giant unilamellar vesicles
(GUVs) showed a preferential localization into Ld domains for both
peptides labeledwith rhodamine at the N-terminus. Thus, we propose
a model according to which: i) the various MPER hydrophobic
modules may differentially affect the bilayer elastic properties; and ii)
the local conﬁnement into small ﬂuid domains might elicit mem-
brane-disrupting MPER activity during fusion.
2. Materials and methods
2.1. Materials
The MPER-derived NEQELLELDKWASLWNWFNITNWLWYIK
(NpreTM) and KKKNWFDITNWLWYIKLFIMIVGGLVKK (CpreTM) pep-
tides and their ﬂuorescent derivatives rhodamine-labeled at the N-
terminus were produced by solid-phase synthesis using FmocCpreTM peptides employed in this study. FP, fusion peptide; NHR and CHR, amino- and
TMD transmembrane domain. The box encloses the 4E10 epitope sequence. Sequences
tioning of NpreTM and CpreTM (left and right panels, respectively). Top: ﬂuorescence
oncentrations of POPC:SPM:Chol (2:1:1) LUV. Peptide concentration was 0.5 μM. Lipid
from the fractional change in Trp ﬂuorescence in the previous spectra. The solid lines
s are displayed in Table 1.
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Proteomics Unit of the University Pompeu-Fabra (Barcelona, Spain).
Peptide stock solutions were prepared in dimethylsulfoxide (DMSO,
spectroscopy grade) and the concentrations were determined using a
bicinchoninic acidmicroassay (Pierce, Rockford, IL, USA). 1-Palmitoyl-
2-oleoylphosphatidylcholine (POPC), dioleoyl-phosphatidylcholine
(DOPC), brain sphingomyelin (SPM), cholesterol (Chol), N-(7-nitro-
benz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine (N-NBD-PE)
and N-(lissamine Rhodamine B sulfonyl)phosphatidylethanolamine
(N-Rh-PE) were purchased from Avanti Polar Lipids (Birmingham, AL,
USA). 8-Aminonaphtalene-1,3,6-trisulfonic acid sodium salt (ANTS),
p-xylenebis(pyridinium)bromide (DPX), and 1,1′-dioctadecyl-3,3′-
oxacarbocyanine perchlorate (DiO) were obtained from Molecular
Probes (Junction City, OR, USA). MAb4E10 was obtained from
Polynum Inc., (Vienna, Austria). All other reagents were of analytical
grade.
2.2. Lipid vesicle preparation
Large unilamellar vesicles (LUVs) were prepared according to the
extrusion method [33] in 5 mM Hepes, 100 mM NaCl (pH 7.4) using
membranes with a nominal pore size of 0.1 μm. Distributions of sizes
were estimated by quasielastic light scattering using a Malvern Zeta-
Sizer Nano ZS instrument (Malvern Instruments, Malvern, UK).
Giant unilamellar vesicles (GUVs) of the desired lipid composition
were prepared according to the electroformation method. Brieﬂy, 5 μl
of DOPC:SPM:Chol 2:2:1 (mol:mol) at 1 mg/ml was spread on
platinum wires. After solvent evaporation, electroformation pro-
ceeded at 2.4 V, 10 Hz at room temperature and during 2 h in 350 μl
of a 300mMsucrose solution. An extra half an hour at 2Hz is needed to
ensure proper detachment of theGUVs from thewires. A fraction of the
solution (typically 50 μl) was transferred to 500 μl of phosphate buffer
saline (PBS) in a Lab-Tek® eight-chambered #1.0 borosilicate cover
glass from Nalge Nunc International (Rochester, NY, USA) previously
blocked with 2mg/ml BSA, for confocal microscopy analyses.
2.3. Partitioning into membranes
Peptide incorporation into membranes under our experimental
conditionswas evaluated bymonitoring the change in the emitted Trp
ﬂuorescence. Corrected spectra were recorded at 25 °C using a
FluoroMax-3 (Jobin Ybon, Horiba) and excitation set at 280 nm.
Partitioning curves were subsequently computed from the fractional
changes in emitted Trp ﬂuorescence when titrated with increasing
lipid concentrations. The apparent mole fraction partition coefﬁcients,
Kx(app), were determined by ﬁtting the experimental values to a
hyperbolic function [34]:
F = F0 = 1 +
F max = F0ð Þ−1½  L½ 
K + L½  ð1Þ
where [L] is the lipid concentration and K is the lipid concentration at
which the bound peptide fraction is 0.5. Therefore, Kx(app)=[W]/K
where [W] is the molar concentration of water.
2.4. Leakage assay and mechanism
Vesicle permeabilization was assayed by monitoring the release to
themedium of encapsulated ﬂuorescent ANTS (ANTS/DPX assay [35]).
LUV containing 12.5 mM ANTS, 45 mM DPX, 20 mM NaCl and 5 mM
Hepes was obtained by separating the unencapsulated material by
gel-ﬁltration in a Sephadex G-75 column that was eluted with 5 mM
Hepes and 100 mM NaCl (pH 7.4). Fluorescence measurements were
performed at 25 °C, after setting the ANTS emission at 520 nm and the
excitation at 355 nm. A cutoff ﬁlter (470 nm) was placed between the
sample and the emission monochromator. The baseline leakage (0%)corresponded to the ﬂuorescence of the vesicles at time 0, while 100%
leakage was the ﬂuorescence value obtained after addition of Triton
X-100 (0.5% v/v).
Leakage mechanism was determined following the ANTS/DPX
requenching assay as described [36–39]. The goal of this assay is to
establish the dependence of the quenching inside vesicles (Qin) on the
ANTS fraction outside vesicles (fout). Qin is deﬁned as the ratio
between the ANTS ﬂuorescence inside vesicles at any time (Fi) and its
maximum possible value in the absence of DPX (Fimax). Qin remains
constant and low for any fout value when peptide-induced leakage
follows an “all-or-none” mechanism, i.e., the population of vesicles
consists of those that did not leak at all, and those releasing all of their
aqueous contents. An increase of Qin as a function of fout reveals a
dilution of both quencher and probe in the lumen of the vesicles,
indicating that the leakage mechanism is “graded,” in which vesicles
lose some of their contents. In brief, peptides were assayed within a
range of concentrations allowing ﬁnal leakage extents below 100%
(see Fig. 3A). The peptides were added to stirring mixtures containing
100 μM lipid vesicles with entrapped ANTS (5 mM) and DPX (8 mM)
in 5 mM Hepes. Peptides and vesicles were incubated until the
ﬂuorescence signal leveled off (typically for 60 min). Then, the
decrease in ANTS ﬂuorescence intensity was recorded in each sample
upon sequential quenching of ANTS outside vesicles by externally
added DPX (25 μl aliquots from a 45 mM stock solution were added 4
times). Subsequently, an excess Triton X-100 (25 μl from a 10% w/v
stock) was added to establish the ﬂuorescence intensity
corresponding to complete leakage. Fluorescence intensities were
ﬁnally corrected for dilution. The methodology followed to determine
Qin and fout parameters from these ANTS ﬂuorescence values has been
detailed by Ladokhin et al. [38].
2.5. Analysis of leakage via pore formation
Leakage extents were analyzed according to amathematical model
of pore formation as previously described [40,41]. In brief, the model
assumes that the peptides added into a vesicle suspension bind
become incorporated within the bilayer and aggregate. When an
aggregate within a membrane has reached a critical size, i.e., it
consists of M peptides, a pore can be created within the membrane,
and leakage of encapsulated molecules can occur. It is assumed that
the process of peptide binding is rapid and once a pore has been
formed in a vesicle, all its contents will leak quickly. Thus, this leakage
must be characterized by an “all-or-none” mechanism. Furthermore,
the leakagemust terminate after a certain period to yield ﬁnal extents,
which depend on peptide-to-lipid ratios. The rate and extent of
leakage are assumed to be limited by the rate and extent of formation
of surface aggregates of M or more peptides. In most of the cases the
surface aggregation of the peptides is not irreversible and depends on
Ks=C/D, in which C and D denote on and off rate constants of surface
aggregation. The calculations employ the parameters M (pore size)
and Ks whose magnitude gives a measure of surface aggregation of
peptides, or degree of irreversibility. The calculations use as an input
the partitioning of the peptide and size distribution of vesicles and
simulate the ﬁnal extents of leakage as a function of lipid-to-peptide
ratios.
2.6. Lipid mixing assay for fusion
Membrane lipid mixing was monitored at 25 °C using the
resonance energy transfer (RET) assay, described by Struck et al.
[42]. The assay is based on the dilution of N-NBD-PE and N-Rh-PE.
Dilution due to membrane mixing results in an increased N-NBD-PE
ﬂuorescence. Vesicles containing 0.6 mol% of each probe were mixed
with unlabeled vesicles at 1:4 ratio (ﬁnal lipid concentration, 0.1
mM). The NBD emission was monitored at 530 nmwith the excitation
wavelength set at 465 nm. A cutoff ﬁlter at 515 nmwas used between
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interferences. The ﬂuorescence scale was calibrated such that the zero
level corresponded to the initial residual ﬂuorescence of the labeled
vesicles and the 100% value to complete mixing of all the lipids in the
system. The latter value was set by the ﬂuorescence intensity of
vesicles, labeled with 0.12 mol% of each ﬂuorophore, at the same total
lipid concentration as in the fusion assay.
2.7. Confocal microscopy
Confocal ﬂuorescence microscopy of GUVs was performed at 25 °C
on a commercial LSM710 system from Zeiss (Jena, Germany) with a
laser-scanningmodule and usingmulti-trackmode. The excitation light
from an Ar ion laser at 488 nm, a He-Ne laser at 561 or a He-Ne laser at
633 nm was reﬂected by a dichroic mirror (HFT UV/488/561/633) and
focused through a Zeiss C-Apochromat 40×, numerical aperture 1.2
water immersion objective, onto the sample. The pinhole sizewas set to
40 μmin the green channel and adjusted in the red channel for the same
z thickness. Emitted ﬂuorescence was splitted with the QUASAR
detector of themicroscope and passed through a 505–530 nmbandpass
ﬁlter for the emission of themolecules excited at 488 nm (ﬁrst channel)
or a 650 nm long pass ﬁlter for molecules excited at 633 nm (second
channel). When using excitation laser at 561, a second track was
conﬁgured with a 580 nm long pass ﬁlter. Image processing and
analyses were carried out with ImageJ (rsb.info.nih.gov/ij/).
3. Results
3.1. Partitioning of peptides into vesicles under Lo/Ld ﬂuid
phase coexistence
The schematic in Fig. 1A designates the sequences of the MPER-
based NpreTM and CpreTM peptides employed in this study. NpreTM
comprises an amphipathic-at-interface sequence (AIS, residues 656–
670), which is followed by the aromatic-rich 671–683 stretch [28,43].
NMR structures resolved for a slightly shorter 662–683 sequence in
dodecylphosphocholine micelles disclosed two interfacial helical
domains connected by a short hinge [27]. CpreTM combines the
aromatic-rich 671–683 stretch with an amino terminal 684–693 TMD
sequence that has been implied in gp41 activity [28,44]. The
membrane-activities of these peptides were compared using vesicles
made of POPC:SPM:Chol (2:1:1 mol:mol), a ternary mixture that
undergoes Lo/Ld ﬂuid phase segregation at room temperature [45].
Since the presence of ordered domains might primarily affect
peptide binding [46], we ﬁrst assessed water–membrane partitioning
for both peptides (Fig. 1B). The intrinsic ﬂuorescence of NpreTM and
CpreTM increased upon incubation with the vesicles, which allowed
the estimation of the water–membrane partitioning coefﬁcients. Both
peptides displayed partitioning coefﬁcients in POPC:SPM:Chol vesi-
cles slightly lower than thosemeasured in POPC vesicles (Table 1), but
still higher than 106. Thus, ﬂuid phase coexistence had a marginal
effect on the NpreTM and CpreTM capacities for partitioning, which
were otherwise comparable under our experimental conditions.Table 1
Interaction with vesicles and membrane-disrupting activity of MPER-derived peptides.
Lipid Peptide Kx(app)a Leakage (EC50)b Fusion (EC50)b Ksc
PC:SPM:Chol
(2:1:1)
NpreTM 3×106 1:800 1:60 n/a
CpreTM 3×106 1:4000 N1:25 0.23
PC NpreTM 9×106 1:200 N1:25 n/a
CpreTM 6×106 1:300 N1:25 0.015
a Partitioning coefﬁcients inferred from curves displayed in Fig. 1B, bottom.
b Effective P:L ratios required to achieve 50% of leakage and fusion were derived
through interpolation from the curves displayed in Figs. 2C and 3B, respectively.
c Irreversibility of surface aggregation calculated for a critical number of peptides for
pore formation, M=8.3.2. Accessibility to MAb4E10 from the water phase under Lo/Ld ﬂuid
phase coexistence
The hydrophobicity distribution suggests different degrees of
membrane insertion along the gp41 MPER-TMD region [28,43].
However, experiments applying brominated lipid at different posi-
tions along the acyl chains were consistent with a common overall
location of NpreTM and CpreTM peptides [28], close to the
membrane-interface/hydrocarbon-core boundary, and suggested
only a slightly deeper degree of insertion in the latter case. More
clear evidence to support different NpreTM and CpreTM bilayer
locations was obtained from the accessibility of the membrane-bound
sequences to MAb4E10 [28]. This antibody recognizes the
WFNITNWLW epitope present in both peptides (Fig. 1A) and has
been shown to bind and partially extract this sequence from
membrane-bound MPER-derived peptides [27,47]. Thus, based on
the antibody's capacity to block ongoing leakage promoted by
epitope-containing peptides [47], MAb4E10 accessibility was next
assessed on NpreTM and CpreTM interacting with membranes that
undergo Lo/Ld ﬂuid phase segregation (Fig. 2).
MPER peptides efﬁciently permeabilized POPC:SPM:Chol (2:1:1)
vesicles (Fig. 2A and B, times of peptide addition indicated by “a”).
Subsequent addition of MAb4E10 (“b”) to the ongoing leakage
induced by NpreTM resulted in the sudden termination of the process
(Fig. 2A). In sharp contrast, MAb4E10 did not appreciably affect
CpreTM-induced leakage (Fig. 2B). Finally, the ELISA results displayed
in Fig. 2C conﬁrmed that the used antibody bound to NpreTM and
CpreTM with almost equal afﬁnity. Thus, the absence of effect
observed in leakage experiments could not be ascribed to deﬁcient
epitope recognition in the context of the CpreTM sequence, but rather
to its occlusion in the membrane-bound state.
In conclusion, results displayed in Fig. 2 are consistent with different
accessibility from water to the WFNITNWLW sequence in NpreTM and
CpreTMpeptides bound to POPC:SPM:Cholmembranes, a phenomenon
previously reported for pure POPC vesicles [28]. Thus, at least attending
to the antibody accessibility criterion, the different peptide bilayer
locations observed in pure POPC were retained in the POPC:SPM:Chol
system. This observation suggests that Lo/Ldﬂuid phase segregation did
not overall alter the pattern of peptide insertion.
3.3. Lytic and fusogenic activities of MPER peptides under Lo/Ld ﬂuid
phase coexistence
The membrane-restructuring capacities of NpreTM and CpreTM
were next compared (Figs. 3 and 4, left and right panels, respectively).
Signiﬁcant levels of permeabilization could be attained for both
peptides incubated with vesicles at low P:L-s (b1:1000), indicating
that leakage did not occur as the consequence of the mere addition of
mass to the bilayer. The kinetic traces shown in Fig. 3B panels
compare the maximum leakage extent fractions in POPC:SPM:Chol
(2:1:1) with those in POPC vesicles for similar peptide membrane
doses (solid and dotted lines, respectively). Upon incubation with the
peptides, ANTS release proceeded more gradually in POPC vesicles in
both cases. Thus, these data suggest that pore assembly occurred
faster in the ternary systems as compared to pure POPC vesicles.
Moreover, comparison of the leakage extents demonstrated that
lower membrane doses of both peptides were required to permea-
bilize vesicles made of the ternary mixture (Fig. 3C).
Efﬁcient intervesicular lipid-mixing could be induced by the
NpreTM peptide in POPC:SPM:Chol (2:1:1) vesicles, but not in POPC
vesicles (Fig. 4, left panels). In contrast, similar doses of CpreTM did
not signiﬁcantly promote fusion of the vesicles made of the ternary
mixture (Fig. 4, right panels). Of note, for lipid-mixing to evolve,
NpreTM had to be added at doses (P:L≥1:100) that were approxi-
mately an order of magnitude higher than those required for vesicle
permeabilization. Table 1 compares the membrane activity displayed
Fig. 2. Differential blocking of NpreTM- or CpreTM-induced permeabilization (ANTS/DPX assay) displayed by the 4E10 MAb in POPC:SPM:Chol (2:1:1) vesicles. (A) Inhibition of
ongoing ANTS leakage induced by NpreTM. The LUV suspension (100 μM lipid) was treated with 0.1 μM peptide and subsequently it was supplemented with 20 μg/ml of the 4E10
MAb (addition times indicated by “a” and “b,” respectively). Dotted traces correspond to the control in the absence of antibody. (B) Absence of CpreTM-induced leakage inhibition by
MAb4E10. Conditions otherwise as in the previous panel. (C) The binding of 4E10 MAb to NpreTM or CpreTM immobilized on ELISA plates (ﬁlled and empty symbols, respectively).
Peptides were applied at 1.4 μM. Experimental values have been ﬁtted to adsorption curves (solid and dashed lines for NpreTM and CpreTM values, respectively).
Fig. 3. Release of vesicular aqueous contents (ANTS/DPX assay) induced by NpreTM and CpreTM peptides (left and right panels, respectively). (A) Kinetics of ANTS leakage. Peptides
were added to POPC:SPM:Chol (2:1:1 mole ratio) vesicle suspensions at the indicated peptide-to-lipid ratios. Time of addition, t=50 s (arrow). The lipid concentration was 100 μM.
(B) Fraction of maximum leakage as a function of time. NpreTM or CpreTMwas incubated at the P:L-s of 1:100 and 1:500, respectively, with POPC:SPM:Chol (2:1:1) or POPC vesicles
(solid and dotted lines, respectively). (C) Final extents of leakage. The percentage measured after a 30 min incubation of peptides with POPC:SM:Chol (2:1:1) or POPC vesicles
(circles and squares, respectively) has been plotted as a function of peptide-to-lipid mole ratio (Ri) in the membrane. The lipid concentration was 100 μM.
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Fig. 4. Fusion (lipid-mixing assay) induced by NpreTM and CpreTM peptides (left and right panels, respectively). (A) Kinetics of lipid-mixing between POPC:SPM:Chol (2:1:1 mole
ratio) vesicles. Conditions otherwise as in Fig. 3A. (B) Final extents of fusion. The percentage of lipid-mixing measured after a 30 min incubation of peptides with POPC:SM:Chol
(2:1:1) or POPC vesicles (circles and squares, respectively) has been plotted as a function of peptide-to-lipid mole ratio (Ri) in the membrane. The lipid concentration was 100 μM.
1802 B. Apellániz et al. / Biochimica et Biophysica Acta 1808 (2011) 1797–1805by both peptides in POPC:SPM:Chol (2:1:1) and POPC vesicles. The
lytic activities of both peptides were similarly enhanced under Lo/Ld
ﬂuid phase coexistence, as compared to the POPC system consisting of
a single ﬂuid Ld phase. The main difference observed between
peptides pertained to their fusogenic effect. Incorporation of NpreTM
at doses inducing total permeabilization activated lipid-mixing
between POPC:SPM:Chol (2:1:1) vesicles, while comparable amounts
of CpreTM had almost no effect.Fig. 5. Mechanism of membrane permeabilization in POPC:SM:Chol (2:1:1) vesicles.
Internal quenching (Qin) was measured as a function of the ANTS released (fout) after
incubation with NpreTM or CpreTM (ﬁlled circles and empty circles, respectively).
Means±S.D. of 3 independent experiments are represented.3.4. Leakage mechanism in systems sustaining Lo/Ld domain segregation
Overall, the previous experiments suggest that ﬂuid phase
coexistence did not affect appreciably the amount of MPER peptide
incorporated into vesicles, but rather increased their lytic potency.
Since the change in lipid order could also contribute to alter the
mechanisms of lysis, the mechanism of pore formation was next
analyzed using the requenching method [36–38] (Fig. 5). In previous
works we have reported that NpreTM-induced leakage follows a
“graded” mechanism [28,32]. Accordingly, a transient perturbation of
the permeability barrier occurred coupled to the insertion and/or
structuring of NpreTM peptides within the bilayer. Such interaction
induces only partial release of aqueous contents. In contrast, CpreTM-
induced leakage obeys an “all-or-none” mechanism, consistent with
the assembly of pores that permeabilize the bilayer long enough to
induce total release of the encapsulated ANTS [28,32].
The Qin parameter remained unchanged at all fout values for
CpreTM-induced leakage of POPC:SPM:Chol (2:1:1) vesicles (empty
circles). This absence of dependence of Qin on fout was consistent with
an “all-or-none” mechanism operating in the process of leakage
induced by CpreTM [38]. In contrast, Qin increased with fout in the case
NpreTM-induced leakage (ﬁlled circles), which implies the existence
of a graded release of contents in this case [38,39]. These results
essentially reproduced the observations made in pure POPC vesicles
[28], and therefore suggest that the presence of laterally segregated
ordered domains did not alter the general mechanisms of leakage.3.5. Mathematical modeling of CpreTM-induced leakage
Vesicle permeabilization by peptides that induce “all-or-none”
release of contents can be quantitatively analyzed according to the
mathematical pore model developed by Nir [40,41,48]. Thus, ﬁnal
extents of CpreTM-induced leakage as a function of the peptide dose
were modeled for different values of M (critical number of monomers
per pore unit) and Ks (surface aggregation irreversibility constant)
(Table 1 and Fig. 6). It has been argued that focal points of fusion
might involve the cooperative action of several Env trimers [49,50],
Fig. 6. Pore modeling of leakage extents. (A) Final extents of CpreTM-induced leakage (percentage after 30 min) in POPC:SM:Chol (2:1:1) vesicles as a function of the lipid-to-
peptide mole ratio. The solid curve corresponds to the predicted values calculated for a pore model in which the minimal number of monomers required for pore formation was
M=12. (B) Increase in the surface aggregation irreversibility constant (Ks) and the correlation coefﬁcient (R2) as a function of the critical number of monomers in a pore (M).
Parameters used for the ﬁtting displayed in the previous panel indicated by the asterisk.
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sequences implied in sustaining gp41 function might reﬂect a
physiologically relevant phenomenon [22,43,44]. Consistent with
the multimeric assembly of peptides at the vesicle surface, the quality
of the ﬁtting reached optimal values for models with M=12–14. For
pores of that size, the Ks values were 0.8–1.45, which denotes levels of
surface aggregation irreversibility comparable to those previously
reported for the archetypal pore-forming GALA peptide [40], implying
that the MPER-derived sequences bear an inherent and strong pore-
forming character.
3.6. MPER-derived peptides preferentially partition into Ld domains
The higher rates and extents of leakage measured in the ternary
mixtures for the same peptide membrane doses could be attributed to
speciﬁc effects arising from Ld+Lo coexistence. Explicitly, pore
formation might be boosted by speciﬁc interactions with Chol in raft
domains [24], and/or by the peptide aggregation–insertion facilitated
at domain boundaries [51]. Alternatively, exclusion from ordered
domains and concentration into the disordered ones might promote
surface aggregation and pore-opening [52]. To contrast these
possibilities, we analyzed the binding preferences of CpretM and
NpreTM to the Lo or Ld phases by means of confocal microscopy.
To that end both peptides were ﬂuorescently labeled with
Rhodamine (Rho) at the N-terminus, following a strategy similar to
that described by Vidal and McIntosh [53] to determine the
distribution of transbilayer peptides in intact GUVs. Although useful
in the previous case, the ﬂuorescent label might conceivable interfere
with the membrane-interacting properties of the MPER-based
peptides. However, we inferred that the contribution of N-terminal
Rho moiety to peptide packing and mixing with bilayer lipids would
be minor as compared to that of the array of aromatic and aliphatic
residues present in both peptides. Supporting such assumption, we
have described in a previous work a comparable capacity of Rho-
labeled NpreTM and CpreTM peptides for partitioning fromwater into
GUV bilayers [32]. Moreover, control experiments displayed in Fig. 7A
indicate that the labeled peptides retained their capacity to efﬁciently
permeabilize lipid vesicles. Thus, the main membrane-interacting
properties of NpreTM and CpreTM seemed to be preserved in the Rho-
labeled specimens.
Fig. 7B shows equatorial sections of GUVs electroformed from a
ternary mixture of lipids and Rho-labeled NpreTM and CpreTM
peptides (top and bottom panels, respectively). The vesicles display
Ld phase labeled with the lipophilic probe DiO (depicted in green),
and mostly unlabeled Lo domains. NpreTM and CpreTM co-localized
with DiO indicating that both peptides were concentrated into the
disordered Ld domains and mostly excluded from the tightly packed
Lo domains. The confocal images also excluded the possibility that the
peptides preferentially inserted at the lateral heterogeneities ordefects that may exist within raft-domain boundaries. In conclusion,
the examination of the peptide distribution through confocal
microscopy supports a leakage enhancement mechanism according
to which it is the concentration of NpreTM and CpreTM into the
disordered domains what favors peptide self-association and pore
assembly.
4. Discussion
Current comprehensive models for fusion propose several non-
exclusive mechanisms of curvature generation within the viral
envelope (for recent, updated reviews see: [16,17]). Refolding of the
glycoprotein helical ectodomains may develop forces that can be
transmitted through rigid linkers to promote localized bending of the
viral lipid bilayer. In addition, the shallow insertion of specialized
hydrophobic domainsmay expand the polar head-group region of one
of the monolayers and generate elastic stresses that are released by
bilayer deformation. Yet another mechanism involves coat-like
protein assemblies at the surface of the viral envelope, which might
bend the membrane into a bulge primed for fusion. However, not all
these mechanisms are applicable to HIV-1 Env-mediated fusion. First,
the carboxy helical regions of gp41 ectodomain are not connected
through rigid structures to the membrane-spanning domains. MPER
embedded into membranes has been shown to adopt a bipartite,
kinked structure, and therefore is unlikely to function as an effective
lever to couple mechanically ectodomain refolding and bending
[27,43]. Second, the low spike content (in the order of 10–20 spikes
per virion [49,54]) precludes the formation of protein-coats of the
density required to modulate the overall curvature of the HIV-1
envelope. Thus, gp41-induced envelope curvature most likely relies
on the general mechanism of hydrophobic insertion [17,43].
Our data in this work support such hypothesis. We report distinct
membrane-restructuring effects induced by MPER-derived NpreTM
and CpreTM peptides, which denote the ability of these sequences to
induce curvature stress in lipid membranes. Both peptides were lytic
and this activity was enhanced for the same membrane doses in
systems exhibiting ﬂuid phase coexistence (Figs. 3 and 4). In addition,
NpreTM, predicted to associate more tightly to the membrane
interface (Fig. 2), induced lipid-mixing at high membrane loads in
the ternarymixture (Fig. 4).We infer that these observationsmight be
explained attending to the conﬁnement/concentration of the peptides
into Ld phases and the varying hydrophobic-hydrophilic sections
along the MPER sequence.
The results described in this work also conﬁrm the similar
accessibility of antibody to 4E10 epitope (Fig. 2), and the comparable
basic mechanisms of membrane permeabilization (Figs. 5 and 6) in
ternary mixtures and POPC vesicles [28]. However, in the case of “all-
or-none” leakage induced by CpreTM, mathematical modeling
rendered for the ternary mixtures Ks values that were approximately
Fig. 7. Determination of the distribution of NpreTM and CpreTM in ﬂuid domains using Rho-labeled peptides. (A) Release of aqueous contents induced by Rho-labeled NpreTM and
CpreTM peptides (left and right panel, respectively), added to POPC:SPM:Chol (2:1:1 mole ratio) vesicle suspensions at 1:100 and 1:250 peptide-to-lipid ratios, respectively. The
lipid concentration was 100 μM. (B) Confocal images of DOPC:SM:Chol (2:2.1) GUVs labeled with DiO (depicted in green) that contain Rho-labeled NpreTM and CpreTM (top and
bottom panels, respectively). The left panels display Ld domain labeling by the ﬂuorescent lipid. The center panels show the rhodamine ﬂuorescence arising from peptides. The right
panels are color-merged images.
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Thus, the higher irreversibility of surface aggregation might increase
the probability of pore formation by CpreTM in membranes that
undergo ﬂuid phase coexistence. A direct proof for peptide accumu-
lation at the Ld phases was subsequently obtained through confocal
microscopy of single vesicles (Fig. 7). Altogether, these observations
are consistent with an increase in the on-rate constant of surface
aggregation in peptide-enriched Ld domains, following the same
mechanism proposed by Pokorny and Almeida to explain the higher
lytic efﬁciency of δ-lysin in raft-containing vesicles [52].
In addition to more effective leakage, concentration into the Ld
phases led to intervesicular lipid-mixing in the case of the NpreTM
peptide. Thus, the differences between NpreTM and CpreTM-induced
membrane-restructuring activities relate to the leakage mechanism
(“graded” vs. “all-or-none”), but also to the capacity of the former for
inducing fusion. It is likely that high doses of NpreTM at membrane
interfaces may promote stresses that compromise bilayer continuity
and the exposure of hydrophobic patches. In contrast, it seems that
higher amounts of CpreTM can be accommodated into the surface of
the Ld phases without compromising the overall bilayer architecture.
In conclusion, our results provide further evidence to support the
different membrane-disrupting effects of MPER hydrophobic modules
during gp41-induced fusion. Accumulation of raft lipids at the viral
envelope implies that the HIV-1 glycoprotein mediates a fusion
process between overall highly ordered bilayers [4]. It is thereforepredicted that the high cohesion of SPM-Chol mixtures, which poses a
limit to the stretching and bending capacities of the lipid bilayer [55],
will also restrict MPER insertion into the envelope and counteract the
ensuing deformations. In line with that idea, our results suggest that
membrane deformation would be maximal if MPER interactions were
restricted to a small area of disordered lipids within the envelope.
Although the viral envelope composition is likely to sustain phase
behaviors more complex than those determined for pure POPC:SPM:
Chol mixtures, the mole percentages of SPM and Chol (18 and 45%,
respectively [3]) actually suggest that the HIV membrane may lie
close to the boundary between Lo/Ld coexistence and pure Lo phase
[56]. It has been argued that peptide crowding into small Ld domains
produced under those conditions may be relevant for promoting
membrane permeabilization by cytolytic peptides [52]. Hence, it is
tempting to speculate that HIV fusion promoted by the shallow
insertion of MPER sequences might evolve within small, ﬂuctuating Ld
spots of the viral membrane.Acknowledgements
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